Co-stimulatory molecules play important roles in immune responses. We investigated the effect of Bu-Zhong-Yi-Qi-Tang (TJ-41) on the expression of intercellular adhesion molecule-1 (ICAM-1), B7.1 and B7.2 by peripheral blood mononuclear cells stimulated by interleukin-18 (IL-18) using fluorescence-activated cell sorter analysis. TJ-41 increased IL-18-induced ICAM-1 and B7.2 expression, resulting in enhanced production of tumour necrosis factor-a and interferon-g. These results suggest that TJ-41 enhances IL-18induced cell-mediated immunity and may enhance host defence mechanisms against pathogens. KEY WORDS: BU-ZHONG-YI-QI-TANG (TJ-41); CO-STIMULATORY MOLECULE; INTERCELLULAR ADHESION MOLECULE-1 (ICAM-1); B7.2; INTERLEUKIN-18; INTERFERON-g; TUMOUR NECROSIS FACTOR-a R Tamura, HK Takahashi, D Xue et al. Effects of combined Bu-Zhong-Yi-Qi-Tang and interleukin-18 on monocytes
Introduction
Bu-Zhong-Yi-Qi-Tang (TJ-41) is a traditional Chinese herbal medicine that has been shown to modify various cellular functions. 1 -4 For example, TJ-41 enhanced the effects produced by lipopolysaccharide (LPS), a glycolipid constituent of the outer membrane of Gramnegative bacteria, in human mononuclear cells 2 and murine macrophages, 3, 4 and increased resistance to infection by Gramnegative bacteria. 5 -8 A recent report demonstrated that TJ-41 enhanced the expression of toll-like receptor 4 (TLR4), 9 which has been identified as an important component of innate immunity and is the main protein involved in the transmission of LPS effects via induction of the transcription factor nuclear factor-κB (NF-κB). 10 -12 TLR4 is expressed in human monocytes, 13 in which its surface expression is modulated by interferon-γ (IFN-γ). 14 Previous reports have demonstrated that TLR4 modulates not only LPS-induced mediator production, 15 -17 but also resistance to bacteria. 18 -21 In light of this, it is tempting to speculate that TJ-41 induces an increase in the TLR4 response to Gram-negative bacteria, enhancing the host's defences against these pathogens.
Interleukin-18 (IL-18), originally described as IFN-γ-inducing factor, was first purified from the conditioned medium of Kupffer cells stimulated with LPS and Propionibacterium acnes. 22 Monocytes and macrophages, when acting as antigen-presenting cells (APCs), produce IL-18 during interactions with cognate T-cells, 23 and IL-18 plays a role in the expression of T helper 1 (Th1) cell responses. 24, 25 In an established Th1 clone, the levels of IFN-γ induced by IL-18 were higher than those induced by IL-12. 22 IL-18 acts in synergy with IL-12 to induce IFN-γ production in T-cells via different signalling pathways, 24, 26 and both IL-12 and IL-18 are necessary for the full expression of the Th1 response. To our knowledge, no other mediators apart from IL-12 have been found to show synergy with IL-18 in the induction of IFN-γ. IL-18 enhances T-cell and natural killer (NK) cell cytotoxicity, and directly induces IFN-γ production by NK cells. 25 The acquired immune response requires the engagement of T-cells with APCs, mediated by interaction of the T-cell receptor with antigenic peptides presented by major histocompatibility complex molecules on the APCs. 27 For T-cell activation, co-stimulatory signals are required from accessory receptors. 28 The interaction of leucocyte function-associated antigen-1 (LFA-1; CD11a/CD18) with its ligand intercellular adhesion molecule-1 (ICAM-1; CD54), and the binding of CD28 to B7 (B7.1/CD80 or B7.2/CD86) play important roles in cell signalling as well as cell-cell adhesion. We have previously shown that IL-18 upregulated the expression of ICAM-1 in human peripheral blood mononuclear cells (PBMCs) as well as in KG-1, a human myelomonocytic cell line. 29, 30 We examined whether TJ-41 acts in synergy with IL-18 to affect the expression of ICAM-1, B7.1 and B7.2 on human monocytes, using fluorescence-activated cell sorter (FACS) analysis. In addition, we investigated the effects of TJ-41 on IL-18-induced production of tumour necrosis factor-α (TNF-α), IFN-γ and IL-10 in PBMCs.
Materials and methods

REAGENTS AND DRUGS
Lipopolysaccharide from Escherichia coli (L8274, serotype 026:B6, purification > 97%) was purchased from Sigma Chemical (St Louis, Missouri, USA). Pure water produced by Millipore (Millipore Japan, Tokyo, Japan) was used as the solvent solution for LPS. Recombinant human IL-18 was purchased from MBL (Nagoya, Japan). TJ-41 was kindly provided by Tumura (Tokyo, Japan). For the flow cytometric analysis, fluorescein isothiocyanate (FITC)-conjugated mouse immunoglobulin G1 (IgG1) monoclonal antibody against ICAM-1/CD54 (6.5B5) and phycoerythrin (PE)-conjugated anti-CD14 monoclonal antibody were purchased from Dako (Glostrup, Denmark). FITC-conjugated mouse IgG1 monoclonal antibody against B7.1 (MAB104) was purchased from Immunotech (Marseille, France). FITC-conjugated mouse IgG1 monoclonal antibody against B7.2 (2331FUN-1) was purchased from Pharmingen (San Diego, California, USA). FITC-conjugated MOPC 21, an IgG1 class-matched control (CMC), was purchased from Sigma Chemical. Endotoxin concentrations in the IL-18 and TJ-41 solutions described above were determined using the Endospecy kit (Seikagaku Kogyo, Tokyo, Japan), which has a lower limit of detection of 0.06 endotoxin units/ml.
ISOLATION OF PERIPHERAL BLOOD MONONUCLEAR CELLS
Normal PBMCs were obtained from human volunteers who had given oral informed consent. Samples of 50 ml of peripheral blood were withdrawn from a forearm vein. PBMCs were isolated from the buffy coat of 10 healthy volunteers by centrifugation using Ficoll-Paque TM (Pharmacia, Uppsala, Sweden), and then washed three times in RPMI 1640 medium (Nissui Co. Ltd, Tokyo, Japan) supplemented with 10% (v/v) heatinactivated fetal calf serum (FCS), 20 µg/ml of kanamycin and 100 µg/ml of streptomycin and penicillin (Sigma). The PBMCs were suspended at a final concentration of 1 × 10 6 cells/ml in RPMI 1640 medium supplemented with 10% (v/v) heatinactivated FCS. The endotoxin concentrations of the medium were again determined using the Endospecy kit.
FLOW CYTOMETRY ANALYSIS
Changes in the expression of human leucocyte antigens ICAM-1, B7.1 and B7.2 on monocytes were examined by doublelabelling flow cytometry using a combination of anti-CD14 antibody with anti-ICAM-1 antibody, anti-B7.1 antibody or anti-B7.2 antibody. PBMCs (1 × 10 6 cells/ml) were cultured in medium containing increasing concentrations of TJ-41 (0 -10 000 ng/ml) in the presence or absence of LPS (1 ng/ml) and IL-18 (100 ng/ml), at 37°C in a humidified atmosphere of 5% CO 2 in air for 24 h. The cultured cells (5 × 10 5 cells/ml) were then washed twice with washing buffer (phosphate buffered saline supplemented with 2.5% normal horse serum, 0.1% NaN 3 and 0.01 M HEPES, pH 7.3) and incubated with 1 mg of FITC-conjugated anti-ICAM-1 antibody, anti-B7.1 antibody, anti-B7.2 antibody or CMC, and phycoerythrin (PE)conjugated anti-CD14 antibody for 20 min at 4°C. After incubation the cells were washed, fixed with 2% paraformaldehyde and analysed using a FACSCalibur TM system (BD Biosciences, San Jose, California, USA).
The data were processed using the BD CELLQuest TM (BD Biosciences) program, and are expressed as the relative fluorescent intensity compared with the CMC (MOPC 21). The results are the mean ± SEM of five independent experiments.
CYTOKINE ASSAYS
Peripheral blood mononuclear cells (1 × 10 6 cells/ml) were incubated with increasing concentrations of TJ-41 (0 -10 000 ng/ml) in the presence or absence of IL-18 (100 ng/ml) for 24 h at 37°C in a humidified atmosphere of 5% CO 2 in air. After culture, cell-free supernatant fractions were assayed for TNF-α, IFN-γ, IL-10 protein and LPS by enzymelinked immunosorbent assay (ELISA) using commercially-available kits (Quantikine, R&D Systems, Minneapolis, Minnesota, USA). All experiments were performed at least in triplicate. The results are the mean ± SEM of five independent experiments.
STATISTICAL ANALYSIS
The statistical significance of differences was evaluated by analysis of variance (ANOVA), followed by the Student's two-tailed t-test. A P-value < 0.05 was considered statistically significant.
Results
EFFECTS OF TJ-41 ON LPS/IL-18-INDUCED ICAM-1, B7.1 AND B7.2 EXPRESSION
Bu-Zhong-Yi-Qi-Tang had no effect on the expression of ICAM-1, B7.1 and B7.2 in the absence (Fig. 1A) or presence (Fig. 1B) of LPS. IL-18 alone (Fig. 1C ) upregulated the expression of ICAM-1 and B7.2. TJ-41 showed an additive effect on the IL-18induced expression of these adhesion molecules in a concentration-dependent manner, but had no effect on the expression of B7.1 (Fig. 1C ). Effects of combined Bu-Zhong-Yi-Qi-Tang and interleukin-18 on monocytes 
EFFECTS OF TJ-41 ON LPS/IL-18-INDUCED TNF-a, IFN-g AND IL-10 PRODUCTION
Interleukin-18 induced the production of TNF-α and IFN-γ, but inhibited the production of IL-10. While TJ-41 had no effect on the production of TNF-α and IFN-γ in the absence of IL-18 ( Fig.  2A) , it showed an additive effect on the IL-18induced production of TNF-α and IFN-γ (Fig.  2B) . TJ-41 did not affect the production of IL-10 even in the presence of IL-18 (Fig. 2B ). In the presence of LPS, TJ-41 had no effect on cytokine production (data not shown).
Discussion
The involvement of co-stimulatory molecules in the interaction between monocytes and T-cells is important for cytokine induction.
Our study examined whether expression of ICAM-1, B7.1 and B7.2 on human monocytes, as well as production of TNF-α, IFN-γ and IL-10, were enhanced or not by incubation with TJ-41.
Interleukin-18 plays an important role in the innate and acquired immune responses. 22 -25 It has been shown to upregulate the expression of ICAM-1 on human monocytes, 29, 30 and in the same concentration range stimulated the production of IL-12, TNF-α and IFN-γ in cultures of human PBMCs. However, the IL-18-induced expression of ICAM-1 in monocytes was independent of IL-18-elicited IL-12, TNF-α and IFN-γ production. 29 Anti-ICAM-1, anti-LFA-1 and anti-B7.2 antibodies not only prevented IL-18-induced aggregation of PBMCs, but also downregulated IL-18-induced production of IL-12, TNF-α and IFN-γ. 29 These findings strongly indicate that interaction between monocytes and T-cells is important for enhanced cytokine induction.
Interleukin-18 in synergy with IL-12 induces the production of IFN-γ in T-and NK cells. 24, 26 The underlying mechanisms involved in this synergism have been suggested to include upregulation of the IL-18 or IL-12 receptor by mutual cytokine stimulation. 24, 31, 32 We have previously reported that the combined effect of IL-18 and IL-12 on IFN-γ production in PBMCs was due to a synergistic effect of these two cytokines on ICAM-1 expression on monocytes, with the subsequent ICAM-1/LFA-1 interaction playing an important role in the enhanced production of IFN-γ. 33 It is therefore possible that the enhancing effect of TJ-41 and IL-18 on IFN-γ production is, at least in part, due to enhanced cell-cell interactions between monocytes and T-cells through increased expression of ICAM-1 and B7.2 on monocytes.
Recent reports have suggested that the TLR4 signal transduction cascade also stimulates NF-κB and c-Jun N-terminal kinase (JNK), and upregulated chemokines and adhesion molecules (such as ICAM-1 and vascular cell adhesion molecule-1 [VCAM-1]) in human hepatic stellate cells, 34 synovial fibroblasts 35 and human coronary artery endothelial cells. 36 It has been clearly demonstrated that TJ-41 enhanced TLR4 surface expression in human monocytic cells (THP-1), 9 and it is therefore reasonable to speculate that TJ-41 could increase the expression of ICAM-1 and B7.2 on monocytes via TLR4 signalling. In the present study, TJ-41 showed an additive effect on IL-18-induced ICAM-1 and B7.2 expression on monocytes, and this effect may be due to additive signalling by the TLR4 and IL-18 receptors for ICAM-1 and B7.2 expression. The subsequent adhesive interactions via ICAM-1/LFA-1 and B7.2/ CD28 generate additional stimulatory signalling, resulting in enhanced production of TNF-α and IFN-γ in monocytes and T-and NK cells, respectively.
In our study, TJ-41 did not show an additive effect with LPS in the induction of the expression of ICAM-1, B7.1 and B7.2 on monocytes. LPS has been reported to upregulate adhesion molecules such as ICAM-1, VCAM-1 and endothelial leucocyte adhesion molecule-1 (ELAM-1), via TLR4 signalling in human hepatic stellate cells and endothelial cells. 34, 36 It is possible that TJ-41 did not act in an additive manner with LPS to induce the expression of ICAM-1, B7.1 and B7.2 on monocytes (due to an LPS-initiated antagonistic effect against the TJ-41-induced stimulation of TLR4), since both LPS and TJ-41 are agonists for TLR4 on monocytes.
The upregulation of co-stimulatory molecules on monocytes may be related to host defence mechanisms against various pathogens. The present research demonstrated that TJ-41 enhanced the IL-18induced expression of ICAM-1 and B7.2, possibly through the induction of TLR4 upregulation. This is the first report of the modulation of co-stimulatory molecules in TJ-41-treated cells. There have been many reports demonstrating that TJ-41 can enhance resistance to infections caused by Gram-negative bacteria and may alleviate their clinical course. 1 -8 Our findings may provide valuable future direction for investigating the relationship between co-stimulatory molecule expression regulation in human monocytes and defence against bacterial pathogens. IL-18 is reported to be an anti-cancer agent, 37,38 so the additive effect of IL-18 and TJ-41 may be a useful anti-cancer treatment.
